[1]
B. Ljungberg, “Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a real-world setting”, SJU, vol. 54, no. 6, pp. 487–492, Nov. 2020.